An observational study from SOLID—TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) showed that increased IL-6 was associated with increased risk of future cardiovascular events, independent of the risk factors present and baseline hsCRP level [29]. Here, IL6 is linked to myocardial infarction.